Measuring Surgical Recovery After Radical Cystectomy

a study on Bladder Cancer Urinary Bladder Tumor

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Sima Porten, MD, MPH
Headshot of Sima Porten
Sima Porten

Description

Summary

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.

Keywords

Bladder Cancer, Registry, Post-surgical outcomes, Radical cystectomy, MD Anderson Symptom inventory, MDASI, Urinary Bladder Neoplasms

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.

You CAN'T join if...

N/A

Locations

  • UCSF accepting new patients
    San Francisco California 94143 United States
  • Stanford University not yet accepting patients
    Stanford California 94305 United States

Lead Scientist at UCSF

  • Sima Porten, MD, MPH
    Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
M.D. Anderson Cancer Center
Links
M D Anderson Cancer Center
ID
NCT03193970
Study Type
Observational [Patient Registry]
Participants
Expecting 20000 study participants
Last Updated
Contact us about this trial